Cargando…
9G Test(TM) Cancer/Lung: A Desirable Companion to LDCT for Lung Cancer Screening
SIMPLE SUMMARY: Lung cancer is the most common cause of cancer-related deaths globally. Patients diagnosed at early-stage (0–I) have a higher survival rate than the metastasized stages (III–IV). Thus, there is great potential to reduce mortality by diagnosing lung cancer at stage 0~I through communi...
Autores principales: | Choe, Wonho, Chae, Jeong Don, Lee, Byoung-Hoon, Kim, Sang-Hoon, Park, So Young, Nimse, Satish Balasaheb, Kim, Junghoon, Warkad, Shrikant Dashrath, Song, Keum-Soo, Oh, Ae-Chin, Hong, Young Jun, Kim, Taisun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692999/ https://www.ncbi.nlm.nih.gov/pubmed/33143045 http://dx.doi.org/10.3390/cancers12113192 |
Ejemplares similares
-
ID-Checker Technology
for the Highly Selective Macroscale
Delivery of Anticancer
Agents to the Cancer Cells
por: Song, Keum-soo, et al.
Publicado: (2022) -
Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis
por: Song, Keum-Soo, et al.
Publicado: (2022) -
HCV Detection, Discrimination, and Genotyping Technologies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2018) -
Development of a Method for Screening and Genotyping
of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2020) -
A Novel Method That Allows SNP Discrimination with 160:1 Ratio for Biosensors Based on DNA-DNA Hybridization
por: Nimse, Satish Balasaheb, et al.
Publicado: (2021)